Taxpayer Funding Resumes for Controversial Health Services
Starting July 4, American taxpayers will begin supporting one of the largest providers of what’s called gender-affirming care for children. This provider is also, rather notably, the biggest abortion provider in the country. Not exactly a celebratory note for the nation’s 250th birthday, right?
Last year, the “One Big Beautiful Bill Act,” pushed by President Donald Trump, cut off nearly $800 million in taxpayer-funded Medicaid reimbursements to major abortion providers like Planned Parenthood. This decision significantly impacted the largest abortion chain in America.
In July 2025 alone, Planned Parenthood closed down 25 clinics, with a total of 47 closures reported since then. It appears they struggle to operate without substantial financial backing from the taxpayer base, which largely doesn’t wish to support their services.
While the defunding in the “One Big, Beautiful Bill” marked a pivotal victory for the pro-life movement, that status will lapse on July 4, 2026. Just in time for the 250th anniversary, taxpayers will once again be financially responsible for the nation’s leading abortion enterprise.
What many may not realize is that funding Planned Parenthood also bolsters one of the top providers of gender-affirming care, which includes cross-sex hormones, puberty blockers, and referrals for various medical procedures.
A 2025 study revealed that 80% of Planned Parenthood clinics offer gender-affirming care, while 70% perform abortions. This statistic is striking; more clinics are offering services related to gender transition than are providing abortions.
Additionally, an investigation by The Free Press noted that between 2017 and 2023, Planned Parenthood submitted 12,000 insurance claims related to gender services for minors aged 12 to 17. Alarmingly, one in six youths who received cross-sex hormones did so through Planned Parenthood.
According to the Concerned Women for America, Planned Parenthood’s annual reports showed an overwhelming 1,514% jump in transgender services from 2021 to 2022, skyrocketing from 15,902 to 256,550 services.
Planned Parenthood openly boasts about its status in the realm of gender-affirming care, specifically claiming to be the second-largest provider of hormone therapy in the U.S.
Despite shifting cultural opinions regarding hormone treatments and surgical procedures, the organization’s business model increasingly revolves around transitioning vulnerable populations. In contrast, under the Biden administration, there have been notable progressions aimed at curbing these procedures for children. Around 40 pediatric gender-affirming clinics have closed recently, citing the current administration’s directive aimed at protecting minors from these treatments.
Furthermore, the White House has initiated a significant crackdown on the misuse of taxpayer dollars. As we approach another Independence Day, taxpayers are poised to reinvest upwards of $800 million in funds to a corporation known for facilitating abortions and controversial gender treatments—what a way to mark our nation’s anniversary.
It raises questions whether American taxpayers should underwrite a business focused on gender-affirming procedures, especially following the previous year’s successes in addressing concerns over those issues. The aim should be to manage taxpayer money wisely, not to support hormone therapy for adolescents.
Fortunately, there’s an avenue to avoid this July 4 funding. It’s crucial for Congress and the White House to collaborate on creating a bill that would permanently cut funding from major abortion providers.
Planned Parenthood should not have access to taxpayer dollars for providing puberty blockers, cross-sex hormones, and other related referrals for American youth.
Any organization deeply involved in controversial medical practices, particularly regarding children, should not receive financial support from taxpayers.
